Recent Certifications & Approvals

Indena

April 6, 2010

The European Directorate for the Quality of Medicines (EDQM) has granted Indena, Milan, Italy, a “Certificate of Suitability of the European Pharmacopoeia” (CEP) for two products: Myrtocyan bilberry fruit dry extract refined and standardized (Vaccinium myrtillus L. dry extract) and Valeroselect valerian dry hydroalcoholic extract. EDQM is the body responsible for granting CEPs to Active Pharmaceutical Ingredients which are covered by European Pharmacopoeia monographs. The purpose of the CEP certification procedure is to provide proof that the quality of the substances used in human and veterinary medicines are suitably controlled by the relevant monographs of the European Pharmacopoeia. These certificates are recognized by all European Union members and other countries, including Australia, Canada and Switzerland.
  • Establishing Specifications as Required by Dietary Supplement cGMPs

    Establishing Specifications as Required by Dietary Supplement cGMPs

    Seong-Jae Yoo, PhD, & Gabriel Giancaspro, PhD, U.S. Pharmacopeial Convention (USP) ||March 1, 2017
    USP monographs can serve as useful resources to help dietary supplement manufacturers comply with federal standards.

  • Packaging Equipment  Technology Trends

    Packaging Equipment Technology Trends

    Kristin Brooks, Associate Editor, Contract Pharma||March 1, 2017
    Biopharma trends drive advanced equipment capabilities.

  • Go for the Gold

    Go for the Gold

    Tom Branna, Editorial Director||March 1, 2017
    Consumers around the world are tuning in to turmeric’s health benefits.